Class D β-lactamases: Are they all carbapenemases?

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2119-2125

  Antunes, Nuno T ^a   Lamoureaux, Toni L ^a   Toth, Marta ^a   Stewart, Nichole K ^a   Frase, Hilary ^a   Vakulenko, Sergei B ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE CLASS D; CARBAPENEM; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFALOTIN; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; DORIPENEM; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LATAMOXEF; MEROPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; TICARCILLIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CARBOXYLATION; DISSOCIATION CONSTANT; ENZYME KINETICS; ESCHERICHIA COLI; GENE INSERTION SEQUENCE; HYDROLYSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ACINETOBACTER BAUMANNII; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 84896913323     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02522-13     Document Type: Article

References (38)

1. Nordmann P, Guibert M. 1998. Extended-spectrum β-lactamases in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 42:128-131. http://dx.doi.org/10.1093/jac/42.2.128.
2. Queenan AM, Bush K. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458. http://dx.doi.org/10.1128/ CMR.00001-07.
3. Walther-Rasmussen J, Hoiby N. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373-383. http://dx.doi.org/10.1093/jac/dki482. (Pubitemid 43240190)
4. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54:24-38. http://dx.doi.org/10.1128/AAC.01512-08.
5. Aubert D, Poirel L, Ali AB, Goldstein FW, Nordmann P. 2001. OXA-35 is an OXA-10-related β-lactamase from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 48:717-721. http://dx.doi.org/10.1093/jac/48.5.717. (Pubitemid 33100319)
6. Danel F, Hall LM, Duke B, Gur D, Livermore DM. 1999. OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1362-1366. (Pubitemid 29259326)
7. Danel F, Hall LM, Gur D, Livermore DM. 1995. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1881-1884. http://dx.doi.org/10. 1128/AAC.39.8.1881.
8. Danel F, Hall LM, Gur D, Livermore DM. 1997. OXA-15, an extendedspectrum variant of OXA-2 β-lactamase, isolated from a Pseudomonas aeruginosa strain. Antimicrob. Agents Chemother. 41:785-790. (Pubitemid 27150532)
9. Danel F, Hall LM, Gur D, Livermore DM. 1998. OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates. Antimicrob. Agents Chemother. 42:3117-3122. (Pubitemid 28553728)
10. Hall LM, Livermore DM, Gur D, Akova M, Akalin HE. 1993. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:1637-1644. http://dx.doi.org/10. 1128/AAC.37.8.1637. (Pubitemid 23226375)
11. OXA-53) and 6′-N-aminoglycoside acetyltransferase genes [aac(6′)-I30]. J. Antimicrob. Chemother. 54:354-359. http://dx.doi.org/10. 1093/jac/dkh347.
12. Poirel L, Gerome P, De Champs C, Stephanazzi J, Naas T, Nordmann P. 2002. Integron-located oxa-32 gene cassette encoding an extendedspectrum variant of OXA-2 β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:566-569. http://dx.doi.org/10.1128/AAC.46.2.566-569.2002. (Pubitemid 34087218)
13. Evans BA, Hamouda A, Amyes SG. 2013. The rise of carbapenemresistant Acinetobacter baumannii. Curr. Pharm. Des. 19:223-238. http://dx.doi.org/10. 2174/138161213804070285.
14. Zhao WH, Hu ZQ. 2012. Acinetobacter: a potential reservoir and dispenser for β-lactamases. Crit. Rev. Microbiol. 38:30-51. http://dx.doi.org/10. 3109/1040841X.2011.621064.
15. OXA-51-like in non-baumannii Acinetobacter spp. J. Chemother. 21:514-520. http://dx.doi.org/10. 1179/joc.2009.21.5.514.
16. Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P. 2011. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob. Agents Chemother. 55:2420-2423. http://dx.doi.org/10.1128/AAC.01452- 10.
17. Giani T, Conte V, Di Pilato V, Aschbacher R, Weber C, Larcher C, Rossolini GM. 2012. Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative. Antimicrob. Agents Chemother. 56:2211-2213. http://dx.doi.org/10.1128/AAC.00035-12.
18. Glupczynski Y, Huang TD, Bouchahrouf W, Rezende de Castro R, Bauraing C, Gerard M, Verbruggen AM, Deplano A, Denis O, Bogaerts P. 2012. Rapid emergence and spread of OXA-48-producing carbapenemresistant Enterobacteriaceae isolates in Belgian hospitals. Int. J. Antimicrob. Agents 39:168-172. http://dx.doi.org/10.1016/j.ijantimicag.2011.10.005.
19. Kilic A, Aktas Z, Bedir O, Gumral R, Bulut Y, Stratton C, Tang YW, Basustaoglu AC. 2011. Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey. Ann. Clin. Lab. Sci. 41:161-166.
20. Poirel L, Heritier C, Tolun V, Nordmann P. 2004. Emergence of oxa-cillinase- mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22. http://dx.doi.org/10.1128/AAC.48.1.15- 22.2004. (Pubitemid 38040171)
21. Smith CA, Antunes NT, Stewart NK, Toth M, Kumarasiri M, Chang M, Mobashery S, Vakulenko SB. 2013. Structural basis for carbapenemase activity of the OXA-23 β-lactamase from Acinetobacter baumannii. Chem. Biol. 20:1107-1115. http://dx.doi.org/10.1016/j.chembiol.2013.07.015.
22. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-9th ed. Document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
24. Dixon M. 1953. The determination of enzyme inhibitor constants. Biochem. J. 55:170-171.
25. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484. http://dx.doi.org/10.1128/AAC.01464-06. (Pubitemid 47519332)
26. Bou G, Oliver A, Martinez-Beltran J. 2000. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561. http://dx.doi.org/10.1128/AAC.44.6.1556-1561.2000. (Pubitemid 30340794)
27. Docquier JD, Calderone V, De Luca F, Benvenuti M, Giuliani F, Bellucci L, Tafi A, Nordmann P, Botta M, Rossolini GM, Mangani S. 2009. Crystal structure of the OXA-48 β-lactamase reveals mechanistic diversity among class D carbapenemases. Chem. Biol. 16:540-547. http://dx.doi.org/10.1016/j.chembiol. 2009.04.010.
28. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:202-208. http://dx.doi.org/10.1128/AAC.49.1.202-208.2005. (Pubitemid 40065794)
29. Santillana E, Beceiro A, Bou G, Romero A. 2007. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 104:5354-5359. http://dx.doi.org/10. 1073/pnas.0607557104. (Pubitemid 47175684)
30. Verma V, Testero SA, Amini K, Wei W, Liu J, Balachandran N, Monoharan T, Stynes S, Kotra LP, Golemi-Kotra D. 2011. Hydrolytic mechanism of OXA-58 enzyme, a carbapenem-hydrolyzing class D β-lactamase from Acinetobacter baumannii. J. Biol. Chem. 286:37292-37303. http://dx.doi.org/10.1074/jbc.M111.280115.
31. Golemi D, Maveyraud L, Vakulenko S, Samama JP, Mobashery S. 2001. Critical involvement of a carbamylated lysine in catalytic function of class D β-lactamases. Proc. Natl. Acad. Sci. U. S. A. 98:14280-14285. http://dx.doi.org/10.1073/pnas.241442898. (Pubitemid 33121383)
32. De Luca F, Benvenuti M, Carboni F, Pozzi C, Rossolini GM, Mangani S, Docquier JD. 2011. Evolution to carbapenem-hydrolyzing activity in noncarbapenemase class D β-lactamase OXA-10 by rational protein design. Proc. Natl. Acad. Sci. U. S. A. 108:18424-18429. http://dx.doi.org/10.1073/pnas. 1110530108.
33. Heritier C, Poirel L, Aubert D, Nordmann P. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273. http://dx.doi.org/10.1128/AAC.47.1.268-273.2003. (Pubitemid 36070374)
34. Poirel L, Castanheira M, Carrer A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P. 2011. OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 55:2546-2551. http://dx.doi.org/10.1128/AAC.00022-11.
35. Frase H, Shi Q, Testero SA, Mobashery S, Vakulenko SB. 2009. Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of β-lactamases. J. Biol. Chem. 284:29509-29513. http://dx.doi.org/10.1074/jbc.M109.011262.
36. Chen TL, Wu RC, Shaio MF, Fung CP, Cho WL. 2008. Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob. Agents Chemother. 52:2573-2580. http://dx.doi.org/10.1128/AAC.00393-08. (Pubitemid 351915690)
37. Heritier C, Poirel L, Lambert T, Nordmann P. 2005. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:3198-3202. http://dx.doi.org/10.1128/AAC.49.8.3198-3202.2005. (Pubitemid 41060561)
38. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. 2003. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547. http://dx.doi.org/10.1128/JCM.41.8.3542-3547.2003. (Pubitemid 36994680)